The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects--a double blind placebo-controlled, crossover study

Randomized Controlled Trial

doi: 10.1016/j.clnu.2005.12.012. Epub 2006 May 15.

Affiliations

PMID: 16698134
DOI: 10.1016/j.clnu.2005.12.012

Randomized Controlled Trial

George B Kudolo et al. Clin Nutr. 2006 Aug.

Abstract

Background & aims: Ginkgo biloba extract (EGb 761) has been shown to ameliorate some defects associated with the insulin resistance syndrome and so patients with Type 2 diabetes mellitus (T2DM) may be inclined to co-ingest the herb with their medications, such as metformin. This study was designed to determine if the co-ingestion of EGb 761 and metformin would alter the pharmacokinetic properties of metformin in T2DM patients and persons without diabetes, who may ingest it for other purposes.

Method: Normal glucose tolerance (NGT) subjects (n=10; age, 39.2+/-14.0 years; fasting plasma glucose (FPG), 90+/-7 mg/dl; body mass index (BMI), 24.1+/-3.7 kg/m(2)) and 10 T2DM patients (n=10; age, 51.7+/-8.9 years; FPG, 150+/-7 mg/dl; BMI, 33.7+/-5.7 kg/m(2)) completed a randomized, double-blind, placebo-controlled crossover study. They ingested either EGb 761 (12 0mg/day as a single dose) or a vegetable-based placebo during each arm for 3 months. At the end of each arm, the NGT subject ingested a single 500 mg dose of metformin (non-diabetics) and the T2DM subject took his/her prescribed metformin dose (250-850 mg) with 120 mg EGb 761. Blood and urine samples were collected over an 8-h period, and in the case of T2DM subjects, additionally over the first 2h of the subsequent 3 days.

Results: Ingestion of EGb 761 produced no significant changes in diagnostic laboratory tests in either group, except reducing glycosylated hemoglobin A(1c) levels (from 7.7+/-1.2 to 7.2+/-0.9%, P<0.05) in T2DM the subjects. The pharmacokinetic parameters of metformin were all significantly different (P<0.05) between the NGT (500 mg) and 8 out of 10 of the T2DM subjects who were prescribed 500 mg of metformin during the placebo cycles. During the EGb 761 cycles, only the elimination half-life in the T2DM subjects was significantly increased (0.117+/-0.085 to 0.141+/-0.100, P<0.05).

Conclusion: The co-ingestion of 120 mg of EGb 761 and 500 mg of metformin did not significantly affect the pharmacokinetic properties of metformin. Further studies are required to verify this observation for smaller and larger dose of metformin with other doses of EGb 761, since T2DM patients on medication constitute a very heterogeneous group.

PubMed Disclaimer

Comment in

Cited by

Clinical pharmacokinetics of metformin.
Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, Furlong TJ, Greenfield JR, Greenup LC, Kirkpatrick CM, Ray JE, Timmins P, Williams KM. Graham GG, et al. Clin Pharmacokinet. 2011 Feb;50(2):81-98. doi: 10.2165/11534750-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21241070 Review.
Treating type 2 diabetes mellitus with traditional chinese and Indian medicinal herbs.
Wang Z, Wang J, Chan P. Wang Z, et al. Evid Based Complement Alternat Med. 2013;2013:343594. doi: 10.1155/2013/343594. Epub 2013 May 7. Evid Based Complement Alternat Med. 2013. PMID: 23737828 Free PMC article.
From traditional medicine to nanomedicine: potential of Ginkgo biloba extracts in treating inflammatory skin diseases.
Chummun Phul I, Gómez-Llonín A, Bhaw-Luximon A. Chummun Phul I, et al. RSC Med Chem. 2024 Jun 11;15(8):2643-2656. doi: 10.1039/d4md00194j. eCollection 2024 Aug 14. RSC Med Chem. 2024. PMID: 39149101 Review.
Licorice ethanol extract improves symptoms of polycytic ovary syndrome in Letrozole-induced female rats.
Yang H, Kim HJ, Pyun BJ, Lee HW. Yang H, et al. Integr Med Res. 2018 Sep;7(3):264-270. doi: 10.1016/j.imr.2018.05.003. Epub 2018 May 30. Integr Med Res. 2018. PMID: 30271715 Free PMC article.
Beneficial effects of Ginkgo biloba extract on insulin signaling cascade, dyslipidemia, and body adiposity of diet-induced obese rats.
Banin RM, Hirata BK, Andrade IS, Zemdegs JC, Clemente AP, Dornellas AP, Boldarine VT, Estadella D, Albuquerque KT, Oyama LM, Ribeiro EB, Telles MM. Banin RM, et al. Braz J Med Biol Res. 2014 Sep;47(9):780-8. doi: 10.1590/1414-431x20142983. Epub 2014 Jul 25. Braz J Med Biol Res. 2014. PMID: 25075573 Free PMC article.

The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects--a double blind placebo-controlled, crossover study - PubMed (original) (raw)